
Xilio Therapeutics to Present at TD Cowen’s 45th Annual Health Care Conference: Insights from a Professionally-Focused Biotech Company
Xilio Therapeutics: RenĂ© Russo, CEO to Speak at TD Cowen Health Care Conference Xilio Therapeutics, a clinical-stage biotechnology company focused on the discovery and development of tumor-activated immuno-oncology therapies for individuals battling cancer, recently announced that its president and CEO, RenĂ© Russo, Pharm.D., will participate in a fireside chat at the TD Cowen 45th Annual…